alpha-fluoro-beta-alanine has been researched along with Central Nervous System Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baccanari, DP; Davis, ST; Joyner, SS; Spector, T | 1 |
1 other study(ies) available for alpha-fluoro-beta-alanine and Central Nervous System Disease
| Article | Year |
|---|---|
5-Ethynyluracil (776C85): protection from 5-fluorouracil-induced neurotoxicity in dogs.
Topics: Animals; beta-Alanine; Central Nervous System Diseases; Dihydrouracil Dehydrogenase (NADP); Dogs; Dose-Response Relationship, Drug; Fluorouracil; Infusions, Intravenous; Male; Oxidoreductases; Uracil | 1994 |